Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
How It Works 
News - Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI Summary - About
Inspire Medical Systems Inc(INSP)
Advisory History & Simulated Performance *
*as per simulation (see disclosures)- ALL
- 1Y
- 1M
- 1W
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- PASS (Skip)
Stock price based on last close Advisory Performance History (Simulated)
Upturn Advisory & Investor View for INSP
10/23/2026: INSP (1-star) is currently NOT-A-BUY. Pass it for now.
Inspire Medical Systems is a growth-oriented medical technology company focused on its proprietary neurostimulation system for treating moderate-to-severe obstructive sleep apnea. Its primary strength lies in providing a proven alternative for patients unable to tolerate standard PAP therapy, backed by an expanding base of trained physicians. The key growth story involves capturing a large, underserved patient population as insurance reimbursement policies improve. However, investors must weigh these opportunities against competitive risks from large sleep-technology incumbents, high procedural costs, and the regulatory nature of the business. This stock is best suited for growth investors who can tolerate the volatility associated with scaling a niche medical device company.
How to Read the Upturn Advisory
The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.
Company fundamentals, valuation, risks, and news provide supporting context about the business.
Investor Fit
| Investor style | Fit | Why |
|---|---|---|
| Growth investor | Strong fit | The company operates in a high-growth niche with significant runway for market penetration. |
| Momentum investor | Mixed fit | The stock exhibits significant price volatility linked to quarterly performance and market sentiment. |
| Value investor | Weak fit | The company is valued primarily on future growth prospects rather than current earnings or low price-to-book ratios. |
| Dividend investor | Weak fit | Inspire does not pay dividends, prioritizing cash for growth and commercialization. |
| Low-risk investor | Weak fit | The stock is subject to clinical, regulatory, and reimbursement risks inherent in the medical device sector. |
Risk Profile
| Risk factor | Level | Why it matters |
|---|---|---|
| Price volatility | High | The stock is subject to significant swings based on clinical trial results and insurance reimbursement shifts. |
| Valuation risk | Medium / high | High growth expectations are priced into the stock, leaving little margin for error in earnings reports. |
| Competition risk (PAP incumbents) | Medium | Established players like ResMed maintain a dominant market position with well-entrenched, lower-cost therapies. |
| Business quality | Medium | The company has a strong proprietary offering but is still in the phase of achieving consistent profitability. |
| Dividend income | Low / none | Income-focused investors should look elsewhere as all capital is reinvested. |
| Execution risk | Medium | Continued success depends on effectively training new surgeons and managing a complex patient referral funnel. |
Price Behavior
Steady Uptrend
The stock demonstrates consistent and steady upward price momentum.
Choppy
The stock has experienced frequent reversals and pronounced short-term price swings.
Analysis of Past Performance
Type Stock | Historic Profit -4.78% | Avg. Invested days 37 | Today’s Advisory PASS |
Upturn Advisory Rating  | Upturn Advisory Performance  4.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 10/23/2026 |
Upturn Scorecard
Upturn Star Rating 
Company Fundamentals
Financial Health Rating
Growth Momentum Score
Ownership
Top 5 Institutional Investors
Unit Economics (Per $1K Revenue)
Economic Dimensions
Quantitative Style Profile
Style Classification
Quality Focused
Key Highlights
Company Size Mid-Cap Stock | Market Capitalization 2.10B USD | Price to earnings Ratio 16 | 1Y Target Price 68 |
Price to earnings Ratio 16 | 1Y Target Price 68 | ||
Volume (30-day avg) 899.8K shares | Beta 0.73 | 52 Weeks Range 38.91 - 147.03 | Updated Date 10/22/2026 |
52 Weeks Range 38.91 - 147.03 | Updated Date 10/22/2026 | ||
Dividends yield (FY) - | Basic EPS (TTM) 4.54 |
How Company Makes Money
| Business area | What it includes | Retail investor read |
|---|---|---|
| Inspire System Sales | Sale of the implantable pulse generator, leads, and associated programming technology. | Revenue is generated by selling the hardware required to perform the Inspire therapy procedure. |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Valuation
Trailing PE 16 | Forward PE 59.17 | Enterprise Value 1.70B | Price to Sales(TTM) 2.34 |
Enterprise Value 1.70B | Price to Sales(TTM) 2.34 | ||
Enterprise Value to Revenue 1.9 | Enterprise Value to EBITDA 19.78 | Shares Outstanding 28.91M | Shares Floating 23.27M |
Shares Outstanding 28.91M | Shares Floating 23.27M | ||
Percent Insiders 1.18 | Percent Institutions 129.32 |
Financial Metrics
🧭 Investment Snapshot
Total Revenue (Scale)
Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.
Net Income (Profit)
Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.
Free Cash Flow (Cash Strength)
Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.
📈 Growth & Strength
Operating Income (Core Profit)
Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.
EBITDA (Cash Earnings)
Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.
Gross Profit (Unit Profitability)
Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.
🛡️ Financial Safety
Cash (Liquidity Buffer)
Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.
Total Debt (Leverage Risk)
Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.
Net Working Capital (Short-Term Health)
Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.
🧱 Balance Sheet Strength
Stockholder Equity (Net Worth)
Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.
Total Assets (Asset Base)
The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.
Income Before Tax (Pre-Tax Earnings)
Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.
⚙️ Cost & Drag Factors
Cost of Revenue (Production Cost)
Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.
Total Operating Expenses (Operating Cost)
Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.
Income Tax Expense (Tax Drag)
Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
All company names, trademarks, logos, and brands are the property of their respective owners and are used for identification and informational purposes only. Use of these names, trademarks, and logos does not imply endorsement by their respective owners.